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Abstract 
Morbidity and mortality from colorectal cancer can be decreased by addressing patient barriers to 
colorectal cancer screening; especially among adults who have never been screened. Assessing changes 
in barriers over time may help practitioners better tailor interventions to address patient barriers. We 
assessed among adults ages 50 -75 who have never been screened for colorectal cancer (CRC) which 
barriers predict prospective screening. A sample of 560 adults who had never been screened, recruited 
from Growth for Knowledge’s online panel, completed a baseline and a six-month follow-up survey. Both 
surveys assessed screening barriers after an online intervention that involved conveying tailored 
comparative risk estimates and message framing. Among those who did not get screened, we examined 
the consistency between reported barriers at baseline and at six-month follow-up. At baseline, 
participants identified 27 barriers; some reported no barriers. Among those never screened (n = 362), 
there was a significant increase from baseline to follow-up in five barriers: ‘time/too busy’, ‘no symptoms’, 
‘in good health’, ‘no motivation’, and ‘hadn’t thought about it’. Reporting ‘no barriers’ at baseline was a 
significant predictor of being screened at follow-up (OR = 3.67, 95% CI = 1.44-9.30, p < .007). Among 
people who have never been screened, interventions should focus on addressing the most consistently 
reported barriers (i.e., ‘time/too busy’, and on improving knowledge and beliefs about who should be 
screened and when, as well as attitudes toward screening, to design more efficacious and tailored 
interventions. 
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Abstract 
Morbidity and mortality from colorectal cancer can be decreased by addressing patient barriers 
to colorectal cancer screening; especially among adults who have never been screened. 
Assessing changes in barriers over time may help practitioners better tailor interventions to 
address patient barriers. We assessed among adults ages 50 -75 who have never been screened 
for colorectal cancer (CRC) which barriers predict prospective screening. A sample of 560 adults 
who had never been screened, recruited from Growth for Knowledge’s online panel, completed a 
baseline and a six-month follow-up survey. Both surveys assessed screening barriers after an 
online intervention that involved conveying tailored comparative risk estimates and message 
framing. Among those who did not get screened, we examined the consistency between reported 
barriers at baseline and at six-month follow-up. At baseline, participants identified 27 barriers; 
some reported no barriers. Among those never screened (n = 362), there was a significant 
increase from baseline to follow-up in five barriers: ‘time/too busy’, ‘no symptoms’, ‘in good 
health’, ‘no motivation’, and ‘hadn’t thought about it’. Reporting ‘no barriers’ at baseline was a 
significant predictor of being screened at follow-up (OR = 3.67, 95% CI = 1.44-9.30, p < .007). 
Among people who have never been screened, interventions should focus on addressing the most 
consistently reported barriers (i.e., ‘time/too busy’, and on improving knowledge and beliefs 
about who should be screened and when, as well as attitudes toward screening, to design more 
efficacious and tailored interventions.  
*Corresponding author can be reached at: Cherie.conley@duke.edu  
 
Introduction 
 
In the United States, colorectal cancer (CRC) is the second leading cause of cancer-
related deaths (Honein-AbouHaidar et al., 2016). CRC screening among average risk adults ages 
50 - 75 is effective at reducing incidence, morbidity, and mortality of CRC (Green et al., 2017). 
It is recommended that adults ages 50 - 75 are screened (Centers for Disease Control and 
Prevention, 2019) and there are multiple effective modalities available for CRC screening (Gupta 
et al., 2013). Guaiac and immunochemical-based fecal occult blood tests (FOBT/FIT) check 
stool for blood and can be conducted by individuals at home while sigmoidoscopy and 
colonoscopy procedures allow providers to visually inspect the colon for abnormalities (Gupta et 
al., 2013). Despite effective screening modalities, in 2016 only 67% of adults in the target age 
range of 50 - 75 years were up to date with screening; 25% have never been screened (Centers 
for Disease Control and Prevention, 2019). Because screening saves lives, understanding what 
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inhibits screening among those who have never been screened, that is barriers, is essential 
(Redmond Knight et al., 2015). 
Barriers between adults who have ever versus never been screened vary (Jones, Woolf, et 
al., 2010; Redmond-Knight et al., 2015). Among adults who have ever or never been screened, 
not having a physician’s recommendation (Janz, Wren, Schottenfeld, & Guire, 2003; Klabunde, 
Schenck, & Davis, 2006), bowel preparation (Jones, Devers, Kuzel, & Woolf, 2010), and being 
asymptomatic (Jandorf et al., 2010) are often the most significant barriers for any type of 
screening modality. For those who have never been screened, barriers more frequently reported 
are not knowing the importance of the test (Klabunde et al., 2006), lack of trust of doctors 
(Lasser, Ayanian, Fletcher, & DelVecchio Good, 2008), fear, anxiety, and generally negative 
feelings about the procedure (Dillard, Fagerlin, Dal Cin, Zikmund-Fisher, & Ubel, 2010; Janz et 
al., 2007).  
Beyond variations in reported barriers between adults who have ever and never been 
screened, most research is cross-sectional; this limits our ability to identify which barriers affect 
future screening (Murphy et al., 2014). Assessing barriers at multiple time points can capture 
changes in barriers that may naturally occur over time without intervention (Bastani, Maxwell, & 
Bradford, 1996), uncover potential changes in barriers that can affect staying up to date with 
screening (Murphy et al., 2014), and highlight whether or not interventions affect the types of 
barriers that people find most important (Dillard et al., 2010). Critically, after looking at barriers 
to cancer screening, authors of one study found that barriers which predicted future screening 
were different from those that predicted having been screened in the past. Therefore in this case, 
interventions designed using only cross-sectional barrier data would have targeted the wrong 
barriers (Bastani et al., 1996). Thus, it is important to identify among adults who have not been 
screened which barriers remain stable and change over time as potential targets of intervention, 
especially if further attempts are made to encourage screening. To this end, as part of a six-
month screening intervention study among men and women ages 50 - 75 who have never been 
screened, we explore: 1) which baseline barriers predict screening; and 2) which barriers change 
from the start to the end of the trial. 
 
Methods 
 
Full study details can be found in Lipkus, Johnson, Amarasekara, Pan, and Updegraff 
(2018). In brief, 560 participants were recruited from the panel of the online survey organization, 
Growth for Knowledge (GfK). GfK sampling covers 97% of the U.S. adult population based on 
address. A random sample of panelists aged 50 - 75 were invited to participate in an online 
tailored intervention that included a baseline and a six-month post-baseline follow-up. Those 
invited completed an eligibility screener and were consented if they had no history of any type of 
CRC screening, reported never having CRC, and were interested in participation. The 
intervention consisted of participants first being informed online of their comparative CRC risk 
(e.g., average, above average) relative to others their age and sex. This was followed by 
embedding within each level of risk educational information, including different screening 
modalities, that provided the pros of getting screened (gain-frame messages) or the cons of not 
getting screening (loss-frame messages).   
After review of the educational materials, participants answered questions that included 
barriers. Participants were asked as an open-ended question, “please tell us what, if anything, 
may keep you from getting screened for CRC in the next six months?” At follow-up, participants 
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who did not get screened were asked: “please tell us what has kept you from getting screened for 
CRC within the last six months?” A list of barriers was generated from prior barriers mentioned 
for CRC screening (Katz, Young, Zimmermann, Tatum, & Paskett, 2018; Murphy et al., 2014) 
and participants’ answers. They were coded by two independent researchers; discrepancies were 
resolved by a third researcher. CRC screening was assessed by self-report at follow-up. 
Participants received $15 as well as an incentive through GfK’s incentive structure. The Duke 
University Medical Center IRB approved this study. 
 
Data Analysis 
 
Participant characteristics for the entire sample were calculated using frequencies for 
categorical variables and means for continuous variables. Chi-square tests were used to assess 
any significant demographic differences between participants who did and did not follow up and 
between participants who had been screened and had not been screened at follow-up. Each 
barrier was coded as either reported or not reported for each participant. Fisher’s exact test was 
done to assess any relationships between age, education, or ethnicity and barriers reported. 
Frequencies were used to calculate, rank, and determine reporting of barriers at baseline and 
follow-up. The McNemar’s exact test for paired samples was used to assess changes in reported 
barriers from baseline to follow-up. While the purpose of the intervention was not to change 
barriers, it is possible that receiving risk messages may have influenced perceived barriers. 
Therefore, logistic regression was done to test the main effects and interactions of risk score and 
message framing on each baseline and follow-up barrier, and on changes in reported barriers. 
Regression analysis was done to determine if number of barriers reported predicted screening at 
follow-up (logistic) and to check for any relationship between number of barriers reported and 
risk score or message framing (linear). All analyses were conducted using SAS version 9.3 (SAS 
Institute Inc). 
 
Results 
 
Participant Characteristics   
 
Of the 560 baseline participants, 400 participants completed the follow-up survey; of 
these, 362 never received screening. Most participants at baseline were white (77%), female 
(53%), and married (80%), and had some college or higher level of education (54%). The mean 
age was 60 (SD = 6.24). A significantly higher proportion of people who followed up  
(p = 0.032), and who received screening (p = 0.037), had more years of education than those who 
did not. 
 
Frequency of Barriers at Baseline and Follow-up  
 
Of the 27 identified barriers at baseline (See Table 1), among participants who did not get 
screened (n = 362), the most frequently reported were (1) ‘time/too busy’ (7.7%), (2) ‘fear of the 
procedure’ (6.9%), and (3) ‘cost’ (6.3%).  At follow-up, the most frequently reported barriers 
were (1) ‘time/too busy’ (12.4%), (2) ‘cost’ (8%), and (3) ‘lack of motivation’ (7.7%). Risk score 
and message framing had no effect on type of barrier reported at baseline or follow-up. 
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Table 1  
 
Number of Participants Reporting Each Barrier at Baseline and Follow-Up among Those Who 
Have Never Been Screened (n = 362) 
 
Barrier Reported 
 
Baseline 
n (%) 
Follow-Up 
n (%) 
McNemar’s 
Test 
Statistic 
(p-value) 
Time/too busy  28 (7.7) 45 (12.4) 7.049  (0.012)* 
Fear of procedure/associated risks  25 (6.9) 20 (5.5) 0.807  (0.437) 
Too costly/insurance doesn't cover  23 (6.3) 29 (8.0) 1.059  (0.391) 
None/no barriersa 21 (5.8) 13 (3.6) 2.461 (0.168) 
Dislike the preparation 16 (4.4) 11 (3.0) 1.191 (0.383) 
No insurance  14 (3.9) 21 (5.8) 2.333  (0.189) 
General no need  14 (3.9) 22 (6.1) 2.462  (0.169) 
General lack of motivation  12 (3.3) 24 (7.7) 4.800  (0.043)* 
Dislike/distrust of doctors/medical                            
personnel 
11 (3.0) 12 (3.3) 0.067 (1.000) 
Just don’t want one  10 (2.8) 15 (4.1) 1.190  (0.383) 
General fear    8 (2.2)   6 (1.7) 0.400 (0.754) 
Have other health problems/issues that 
interfere 
  8 (2.2) 11 (3.0) 0.692  (0.581) 
Low risk  7 (1.9)   3 (0.8)             2.000 (0.289) 
Knowing someone who had a negative 
experience 
 7 (1.9)   5 (1.4) 0.400  (0.754) 
No family history   5 (1.4) 10 (2.8) 1.923  (0.267) 
Physician did not recommend   5 (1.4)   8 (2.2) 0.818 (0.549) 
Perceive self in good health   4 (1.1) 13 (3.6) 5.400  (0.035)* 
Othera  4 (1.1)   5 (1.4) 0.100 (1.000) 
Tests are not effective/do not trust tests  4 (1.1)   6 (1.7)  0.400  (0.754) 
Transportation problems/ride home   4 (1.1)   3 (0.8) 0.200  (1.000) 
General dislike of medical procedures  4 (1.1)   4 (1.1) 0.000  (1.000) 
Embarrassment/disgust   4 (1.1)   1 (0.2) 1.800  (0.380) 
Fear of doctors   4 (1.1)   0 (0.0)     -      - 
Fear/anxiety about negative results
  
      4 (1.1)   3 (0.8) 0.200  (1.000) 
Fate (whatever happens will happen) or 
God’s plan 
 4 (1.1)   1 (0.2) 1.800  (0.375) 
No symptoms   3 (0.8) 16 (4.4)  9.940  (0.002)* 
Have not thought about it before  2 (0.5) 11 (3.0) 6.231 (0.023)* 
Pain   2 (0.5)   4 (1.1) 0.667  (0.688) 
Not aware of relevance/not aware why 
it’s important 
 0 (0.0)   1 (0.2)     -      - 
No response givena 159 (43.92) 90 (24.86)   
Note. a ‘No response given’, ‘other’, and ‘no barriers’ were not considered barriers and were not included in the 
group of 27 reported barriers.  
*p-value significant at < 0.05 level 
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We also explored the effect of race/ethnicity, level of education, and age on each barrier 
reported. No significant relationship was found between any reported barrier and demographic 
characteristics.    
 
Barriers Predicting Screening at Follow-up 
 
Of the 400 participants reached at follow-up, 38 (9.5%) reported screening. No individual 
barrier predicted screening. Participants who explicitly stated not having any barrier at baseline 
(n = 21) were more likely to have screened than participants who reported any barrier  
(OR = 3.67, 95% CI = 1.44-9.30, p < .007). Number of barriers at baseline, message framing, 
and risk score did not predict screening.             
 
Changes in Barriers Reported  
 
Five barriers showed significant increases from baseline to follow-up: (1) ‘time/too busy’ 
(p = 0.012), (2) ‘lack of motivation’ (p = 0.043), (3) ‘had not thought about it before’  
(p = 0.023), (4) ‘in good health’ (p = 0.035), and (5) ‘no symptoms’ (p = 0.002) (see Table 1). 
Barriers ‘fear of the procedure’ and ‘dislike of preparation’ were reported less frequently at 
follow-up; however, these changes were not significant. There were no significant relationships 
between risk score and message framing and changes in barriers reported. 
 
Discussion 
 
 In this sample of adults who have never been screened, the most frequently reported 
barriers – ‘fear’, ‘cost’, and ‘time/too busy’ – were similar to those reported in prior studies of 
adults who have never or ever been screened (Jones, Devers, et al., 2010; Katz et al., 2018; 
Kimura, Sin, Spigner, Tran, & Tu, 2014). Among adults who have never been screened, ‘not 
knowing the importance of the screening test’ (Klabunde et al., 2006) and ‘lack of trust in 
doctors’ are more likely to be reported (Lasser et al., 2008). Our findings did not support this. 
One possible reason is that recruitment from an online panel may indicate additional knowledge 
and access to health-related information (Baker et al., 2010). Also in this study, 77% of 
participants were white, and over 50% had some college education – a population more likely to 
have insurance, and receive physician recommendations for screening (Williams et al., 2016); 
although we found no significant relationship between ethnicity and education and reporting of 
any barriers. 
 Individuals who have never been screened report being more fearful than those who have 
been screened (Janz et al., 2007). We found different fears were reported less frequently, though 
not significantly so, at follow-up. This suggests that fear may not be as salient of a barrier as 
reported initially relative to other barriers. Because fear was not consistently reported as a top 
barrier at follow-up, this suggests that barriers to screening should be assessed more than once 
and that barriers which are reported frequently at both time periods are important to prioritize 
when addressing barriers to screening.  
Study findings showed significant increases in reported barriers related to perceiving 
one’s self as being healthy and not needing the test, (i.e., ‘no symptoms’, ‘good health’), and 
attitudes about screening (e.g., ‘no motivation’, ‘hadn’t thought about it’). These may indicate 
more intense education is needed about the disease process as well as screening visit reminders. 
5
Conley et al.: BARRIERS FOR COLORECTAL CANCER SCREENING
Published by New Prairie Press, 2019
Our analysis showed that receiving a CRC risk score and message framing had no significant 
effect on reporting of barriers related to perceptions of personal health (or any others) at baseline 
or follow-up. This finding is consistent with results from the original study which showed higher 
risk adults resisted accepting their comparative risk status (Lipkus et al., 2018).  
Reporting ‘no barriers’ at baseline was a strong predictor of screening. The importance of 
having no barriers indicates the need to assist patients to identify multiple potential barriers 
(Jones, Devers, et al., 2010) along with ways to overcome these barriers such as hearing in 
narratives how others overcame barriers (Dillard et al., 2010), using patient navigators to identify 
and work through barriers (Rice et al., 2017), and encountering tailored messages to address 
patient-specific barriers (Oyalowo, Forde, Lamanna, & Kochman, 2019).  
This study had several limitations. First, although the population of adults who have not 
been screened is disproportionately non-white and of lower socioeconomic position (Jackson, 
Oman, Patel, & Vega, 2016), this sample was more educated and mostly white. Though our 
analysis showed no relationship between ethnicity or education and selected barriers, 
generalizability to the population of adults who have never been screened may be limited. 
Second, we did not ask about barriers in relation to specific screening modalities. Different tests 
may have different barriers; however, by not specifying, participants were free to name any and 
all barriers considered, a potential benefit. Third, this study did not have a control group, which 
may prevent understanding the extent to which the intervention affected results. Hence, the 
causal inferences which can be made are limited. Regardless, regression analysis indicated no 
significant relationships between message framing, risk score, and barriers.     
 
Implications 
 
Strategies are needed to help adults who have never been screened to achieve greater 
insight into and overcome barriers that are most frequently and consistently reported and those 
that become more salient over time. These strategies can help providers target those barriers and 
effectively tailor interventions that encourage screening for the first time and keeping up to date 
with screenings. Successful interventions based on the Health Belief Model that increase feelings 
of susceptibility in the absence of symptoms (Gholampour, Jaderipour, Jeihooni, Kashfi, & 
Harsini, 2018; Moattar, Roozitalab, Gholamzadeh, Firoozi & Zare, 2014) and that increase self-
efficacy to address each barrier may be especially helpful in this population.  
 
Discussion Questions 
 
1. Based on our results, screening rates may be increased if patients are assisted in identifying 
and addressing all barriers – especially in clinic settings. What are the most feasible and 
effective strategies to accomplish this? 
2. Our findings show that ‘time/too busy’ is the most often reported barrier. What types of 
solutions, from new health technologies to community-based approaches, might help patients 
and providers better address this barrier? 
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